Tharimmune appoints prof. david jones of newcastle university to its scientific advisory board

Bridgewater, nj / accesswire / july 22, 2024 / tharimmune, inc . (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, today announced the appointment of david jones, professor of liver immunology at newcastle university in england, to its scientific advisory board (sab).
THAR Ratings Summary
THAR Quant Ranking